UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047501
Receipt number R000054170
Scientific Title A retrospective study to explore the efficacy and safety of FOLFOX therapy and FOLFOX with radiation in esophageal squamous cell carcinoma
Date of disclosure of the study information 2022/04/18
Last modified on 2022/04/15 21:25:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective study to explore the efficacy and safety of FOLFOX therapy and FOLFOX with radiation in esophageal squamous cell carcinoma

Acronym

A retrospective study to explore the efficacy and safety of FOLFOX therapy and FOLFOX with radiation in esophageal squamous cell carcinoma

Scientific Title

A retrospective study to explore the efficacy and safety of FOLFOX therapy and FOLFOX with radiation in esophageal squamous cell carcinoma

Scientific Title:Acronym

A retrospective study to explore the efficacy and safety of FOLFOX therapy and FOLFOX with radiation in esophageal squamous cell carcinoma

Region

Japan


Condition

Condition

esophageal squamous cell carcinoma

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

efficacy

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

CR rate group 1
OS group 2, 3, 4

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The diagnosis of squamous cell carcinoma, adenosquamous cell carcinoma, or basal cell carcinoma (biopsy of the secondary lesion is not required, but if biopsy is performed, the lesion must be squamous cell carcinoma, adenosquamous cell carcinoma, or basal cell carcinoma).
ECOG PS 0-2
No prior chemotherapy, radiation therapy, or surgery (Groups 1-3) (However, patients in Groups 2 and 3 are eligible if they have undergone radical therapy for at least 24 weeks after completion of treatment)
Prior cisplatin (Group 4)
Have evaluable lesions (evaluable lesions are defined as target and non-target lesions)
Treated with FOLFOX monotherapy or chemoradiotherapy with FOLFOX between April 22, 2019 and October 31, 2020. However, patients whose doses are adjusted or reduced according to their general condition in actual clinical practice regarding the standard dosage and administration of chemoradiotherapy and chemotherapy will also be accepted for enrollment.

Key exclusion criteria

Duplicate cancers (simultaneous duplicate cancers and iatrogenic duplicate cancers with a disease-free interval of 3 years or less). However, patients with overlapping cancers that are not prognostic factors are not excluded.
Patients with cardiovascular complications that are not stabilized by pharmacological therapy alone.

Target sample size

180


Research contact person

Name of lead principal investigator

1st name Kazuhiro
Middle name
Last name Shiraishi

Organization

National Hospital Organization Nagoya Medical Center

Division name

Department of Medical Oncology

Zip code

4600001

Address

San-no-Maru, Naka-ku, Nagoya City

TEL

0529511111

Email

yuzushiraishi@gmail.com


Public contact

Name of contact person

1st name Kazuhiro
Middle name
Last name Shiraishi

Organization

National Hospital Organization Nagoya Medical Center

Division name

Department of Medical Oncology

Zip code

4600001

Address

San-no-Maru, Naka-ku, Nagoya City

TEL

0529511111

Homepage URL


Email

yuzushiraishi@gmail.com


Sponsor or person

Institute

National Hospital Organization Nagoya Medical Center, Department of Medical Oncology

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization Nagoya Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Nagoya Medical Center

Address

San-no-Maru, Naka-ku, Nagoya City

Tel

0529511111

Email

311-rec@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

143

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 06 Month 21 Day

Date of IRB

2021 Year 06 Month 21 Day

Anticipated trial start date

2021 Year 06 Month 21 Day

Last follow-up date

2021 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

retrospective observational study


Management information

Registered date

2022 Year 04 Month 15 Day

Last modified on

2022 Year 04 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054170


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name